VORONOI
Voronoi is a biotech company that develops novel kinase inhibitors and target protein degraders.
VORONOI
Social Links:
Industry:
Biotechnology Health Care
Founded:
2015-02-14
Address:
Incheon, Inch'on-jikhalsi, South Korea
Country:
South Korea
Website Url:
http://www.voronoi.io
Total Employee:
101+
Status:
Active
Contact:
032-830-4855
Email Addresses:
[email protected]
Total Funding:
1.2 T KRW
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Google Font API WordPress Google Analytics Google Universal Analytics Pound Sterling Fontello WordPress 5.8
Similar Organizations
Anaxis Pharma
Anaxis Pharma is an Australian Biotech company developing novel inhibitors / modulators of cell death.
Enzyvant Sciences
Enzyvant Sciences is a biotechnology company which focuses on developing treatments for rare diseases.
Mast Therapeutics
Mast Therapeutics is a biopharmaceutical company developing novel, clinical-stage therapies for serious or life-threatening diseases.
Current Employees Featured
Investors List
Nice Investment Partners
Nice Investment Partners investment in Venture Round - Voronoi
Official Site Inspections
http://www.voronoi.io Semrush global rank: 4.92 M Semrush visits lastest month: 1.74 K
- Host name: 203.245.24.8
- IP address: 203.245.24.8
- Location: South Korea
- Latitude: 37.5112
- Longitude: 126.9741
- Timezone: Asia/Seoul
More informations about "Voronoi"
VORONOI
๋ณด๋ก๋ ธ์ด๋ ์นด์ด๋ค์ด์ค (Kinase) ํ์ ์น๋ฃ์ ์ ์ฝ๊ฐ๋ฐ ์ ๋ฌธ๊ธฐ์ ์ ๋๋ค. ์ ๋ฐ์ํ ํ์ ์น๋ฃ์ ์ Target Protein Degrader (TPD) ๊ฐ๋ฐ์ ์ง์คํ์ฌ ์ ๋ฐ ๋์น์ฑ ์งํ์ ๊ทน๋ณต์ ์ํด ๋์๊ฐ๊ณ โฆSee details»
About VORONOI โ VORONOI
By owning an AI Lab, a synthesis Lab for compound design and synthesis and a bio Lab, a preclinical Animal Center for in vitro/in vivo, PK and toxicity evaluation, Voronoi are maximizing โฆSee details»
Visual Capitalist's New App is Now Available!
Dec 13, 2023 Get Visual Capitalist's new app, Voronoi, and discover the world's most interesting data and stories, all on one trusted platform.See details»
About Voronoi - Voronoi by Visual Capitalist
With Voronoi, we aim to unite all those fascinated with data in one place, where visual storytelling, transparency of data sourcing, and community take center stage.See details»
Company โ VORONOI
๋ณด๋ก๋ ธ์ด๋ ์นด์ด๋ค์ด์ค (Kinase) ํ์ ์น๋ฃ์ ์ ์ฝ๊ฐ๋ฐ ์ ๋ฌธ๊ธฐ์ ์ ๋๋ค. ์ ๋ฐ์ํ ํ์ ์น๋ฃ์ ์ Target Protein Degrader (TPD) ๊ฐ๋ฐ์ ์ง์คํ์ฌ ์ ๋ฐ ๋์น์ฑ ์งํ์ ๊ทน๋ณต์ ์ํด ๋์๊ฐ๊ณ ์์ต๋๋ค.See details»
Explore Voronoi by Visual Capitalist: Data-Driven Visual โฆ
Dive into the world of data with Voronoi by Visual Capitalist. Discover captivating visualizations like charts and maps, all sourced transparently from renowned creators globally. Uncover the stories data can tell!See details»
Voronoi by Visual Capitalist - Apps on Google Play
Feb 17, 2025 Voronoi is the ultimate destination for data-driven storytelling. Whether you are interested in investing, staying on top of current events, or any other topic imaginable, this platform helps make a complex world more easy โฆSee details»
Voronoi by Visual Capitalist
Voronoi. Where data tells the story. The new app from Visual Capitalist launching Fall 2023 on iOS and Android.See details»
Voronoi - Crunchbase Company Profile & Funding
Voronoi is a biotech company that develops novel kinase inhibitors and target protein degraders.See details»
Celebrating a Year of Voronoi: Where Data Tells the Story
Dec 10, 2024 From 300,000 active users to millions of views, here's a Data Drop of the numbers that made this year of Voronoi unforgettable.See details»
Investors - Voronoi by Visual Capitalist
Past performance is not indicative of future results. Prospective investors should conduct their own independent investigation and seek advice from financial, legal, and tax professionals โฆSee details»
Voronoi, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Voronoi, Inc. with its drug pipeline, therapeutic area, technology platform, 10 news, and 7 literature, Disease Domain:Neoplasms, Immune System Diseases ...See details»
Our work โ VORONOI
Scientific Advisor: Pasi A. Jänne, MD, PhD Dr. Jänne is the Director of the Lower Center for Thoracic Oncology at Dana-Farber Cancer Institute and a Professor of Medicine at Harvard โฆSee details»
VORONOI Company Profile - Office Locations, Competitors ... - Craft
VORONOI has 5 employees at their 1 location. See insights on VORONOI including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
FAQ - Voronoi by Visual Capitalist
A: The app is named after a specific type of visualization called the voronoi diagram. This type of diagram displays polygons of various sizes within a defined shape, with the area of each โฆSee details»
Voronoi 2025 Company Profile: Stock Performance & Earnings
Information on stock, financials, earnings, subsidiaries, investors, and executives for Voronoi. Use the PitchBook Platform to explore the full profile.See details»
Pipeline โ VORONOI
Voronoi is dedicated to developing drugs that significantly improve the lives of patients with rare and debilitating pulmonary arterial hypertension.See details»
Quickstart Guide for Creators - Voronoi by Visual Capitalist
Data and sourcing โ Most visualizations are backed by data, and on Voronoi, transparency is a priority for our users. In approving posts, we look for a good-faith attempt at providing raw โฆSee details»
The Best Visualizations of January on the Voronoi App
Jan 30, 2025 We round up the most popular, most discussed, and most liked visualizations of the month on Voronoi, our new data storytelling platform.See details»
R&D Platform โ VORONOI
S 18th F,Songdogwahak-ro 32(ITcenter), Yeonsu-gu, Incheon, Republic of KoreaR&D PlatformSee details»